Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy

Journal of Pathology

Volumn 205, Issue 3, 2005, Pages 397-407

  Fiaccavento, Roberta ^a   Carotenuto, Felicia ^a   Minieri, Marilena ^a   Fantini, Cristina ^b   Forte, Giancarlo ^a   Carbone, Arnaldo ^c   Carosella, Luciana ^c   Bei, Roberto ^d   Masuelli, Laura ^e   Palumbo, Camilla ^d   Modesti, Andrea ^d   Prat, Maria ^f   Di Nardo, Paolo ^a  

^a Unversita di Roma 'Tor Vergata'   (Italy)

^b Syntech srl   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Apoptosis; Cardiomyopathy; Cytokines; Myocyte; Stem cells

Indexed keywords

ATAXIN 1; CYCLIN B; CYTOKINE; KI 67 ANTIGEN; MYOCYTE ENHANCER FACTOR 2; MYOSIN HEAVY CHAIN; SCATTER FACTOR; TELOMERASE; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC DISORDER; HAMSTER; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HYPERTROPHIC CARDIOMYOPATHY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL DOCUMENTATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STEM CELL;

ANIMALS; APOPTOSIS; CAPILLARIES; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CRICETINAE; ENDOTHELIUM, VASCULAR; HEART VENTRICLES; HEPATOCYTE GROWTH FACTOR; MESENCHYMAL STEM CELLS; MYOCYTES, CARDIAC;

EID: 13844253775     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1717     Document Type: Article

References (44)

1. Minieri M, Zingarelli M, Shubeita H, et al. Identification of a new missense mutation in the mtDNA of hereditary hypertrophic, but not dilated cardiomyopathic hamsters. Mol Cell Biochem 2003; 252: 73-81.
2. Maass A, Konhilas JP, Stauffer BL, Leinwand LA. From sarcomeric mutations to heart disease: understanding familial hypertrophic cardiomyopathy. Cold Spring Harb Symp Quant Biol 2002; 67: 409-415.
3. Sakamoto A, Abe M, Masaki T. Delineation of genomic deletion in cardiomyopathic hamster. FEBS Lett 1999; 447: 124-128.
4. Arad M, Seidman JC, Seidman CE. Phenotypic diversity in hypertrophyc cardiomyopathy. Hum Mol Genet 2002; 11: 2499-2506.
5. Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 2004; 94: 1023-1031.
6. Nigro V, Okazaki Y, Belsito A. et al. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 1997; 6 601-607.
7. Liu LA, Engvall E. Sarcoglycan isoforms in skeletal muscle. J Biol Chem 1999; 274: 38171-38176.
8. Melacini P, Fanin M, Duggan DJ, et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 1999; 22: 473-479.
9. Coral-Vazquez R, Cohn RD, Moore SA, et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1999; 98: 465-474.
10. Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, McNally E. Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomiophathy. J Clin Invest 2004; 113: 668-675.
11. Durbeej M, Sawatzki SM, Barresi R, et al. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy. Proc Natl Acad Sci USA 2003; 100 8910-8915.
12. Masuelli M, Bei R, Sacchetti P, et al. β-Catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts. Cardiovasc Res 2003; 60: 376-387.
13. Ambra R, Di Nardo P, Fantini C, et al. Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters. Life Sci 2002; 71: 2369-2381.
14. Di Nardo P, Fiaccavento R, Natali A, et al. Embryonic gene expression in nonoverloaded ventricles of hereditary hypertrophic cardiomyopathic hamsters. Lab Invest 1997; 77: 489-502.
15. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100: 10440-10445.
16. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med. 2003; 349: 267-274.
17. Heng BC, Haider HK, Sim EK, Cao T, Ng SC. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res 2004; 62: 34-42.
18. Ohtsuka M, Takano H, Zou Y, et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004; 18: 851-853.
19. Li RK, Li G, Mickle DA, et al. Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 1997; 96: 874-881.
20. Sato T, Yoshinouchi T, Sakamoto T, et al. Hepatocyte growth factor (HGF): a new biochemical marker for acute myocardial infarction. Heart Vessels 1997; 12: 241-246.
21. Sussman MA, Anversa P. Myocardial aging and senescence: where have the stem cells gone? Ann Rev Physiol 2004; 66: 29-48.
22. Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-641.
23. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000; 106: 1511-1519.
24. Rappolee DA, Iyer A, Patel Y. Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circ Res 1996; 78: 1028-1036.
25. Duan HF, Wu CT, Wu DL, et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther 2003; 3: 467-474.
26. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. EXS 1993; 65: 225-249.
27. Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W. Functional expression of HGF and HGF receptor/cmet in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 2004; 22: 405-414.
28. Modesti A, Masuelli L, Modica A, et al. Ultrastructural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma. Int J Cancer 1993; 53: 988-993.
29. Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, Comoglio PM. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem 1995; 270: 603-611.
30. Grano M, Galimi F, Zambonin G, et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Nalt Acad Sci USA 1996; 93: 7644-7648.
31. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-274.
32. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artificial Organs 2001; 25: 187-193.
33. Prat M, Crepaldi T, Gandino, et al. C-terminal truncated forms of Met, the hepatocyte growth factor receptor. Mol Cell Biol 1991; 11: 5954-5962.
34. Claycomb WC, Lanson NA Jr, Stallworth BS, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998; 17: 2979-2984.
35. Medico E, Mongiovi AM, Huff J, et al. The tyrosine kinase receptors Ron and Sea control 'scattering' and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 1996; 7: 495-504.
36. Olivero M, Rizzo M, Madeddu R, et al. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 1996; 74: 1862-1868.
37. Oh H, Taffet GE, Youker KA, et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci USA 2001; 98: 10308-10313.
38. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.
39. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998; 95: 90-92.
40. Leri A, Barlucchi L, Limana F, et al. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci USA 2001; 98: 8626-8631.
41. Miyagi T, Takeno M, Nagafuchi H, Takahashi M, Suzuki N. Flk1+ cells derived from mouse embryonic stem cells reconstitute hematopoiesis in vivo in SCID mice. Exp Hematol 2002; 30: 1444-1453.
42. Schatteman GC, Awad O. Hemangioblasts, angioblasts, and adult endothelial cell progenitors. Anat Rec 2004; 276A: 13-21.
43. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-925.
44. Matsumori A, Furukawa Y, Hashimoto T, et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 1996; 221: 391-395.